tiprankstipranks
Trending News
More News >

Shandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation

Story Highlights
Shandong Xinhua’s Aminophylline Tablets Pass Key Quality Evaluation

Confident Investing Starts Here:

An update from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) is now available.

Shandong Xinhua Pharmaceutical Company Limited announced that its Aminophylline Tablets have passed the Consistency of Quality and Efficacy Evaluation for Generic Drugs, as approved by the National Medical Products Administration. This approval is a significant milestone for the company, potentially enhancing its market position by ensuring the quality and efficacy of its generic drugs, which could lead to increased trust and demand from healthcare providers and patients.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in China, operating within the pharmaceutical industry. The company focuses on the production and distribution of prescription drugs, with a particular emphasis on chemical-based medications.

YTD Price Performance: -7.75%

Average Trading Volume: 2,131,863

Technical Sentiment Signal: Hold

Current Market Cap: HK$8.24B

See more insights into 0719 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App